Pandemic Management Strategies for Patients With Cancer at an Academic Medical Centerhttps://shieldshealthsolutions.com/content/themes/blade/images/empty/thumbnail.jpg150150Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
By Martha Stutsky, PharmD, BCPS; and Osama Abdelghany, PharmD, MHA, BCOP Smilow Cancer Hospital at Yale New Haven Health System in Connecticut is 1 of 45 National Cancer Institute–designated comprehensive…
COVID-19 and the Impact on Oral Oncolytics: A Specialty Pharmacy Perspectivehttps://shieldshealthsolutions.com/content/themes/blade/images/empty/thumbnail.jpg150150Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
By Claudia S. Castro, PharmD, MS, BCOP, BCGP; and Amanda Manoogian, PharmD, BCOP The prevalence of individuals living with cancer continues to rise, largely because of an aging and growing…
ExceleraRx Corp.’s Gerzenshtein to Present at Vanderbilt Health-Systems Specialty Pharmacy Outcomes Research Summithttps://shieldshealthsolutions.com/content/uploads/2021/06/shields-blog-icon-pr-1.svg204115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Wolfe joins Excelera with significant experience in building strategic pharmaceutical manufacturer relationships for publicly traded and private organizations in the healthcare sector
Complex Patient Data Platform Drives Business Intelligencehttps://shieldshealthsolutions.com/content/uploads/2021/06/Payor-Type-All-Hepatitis-C-Completion-of-Therapy-1024x576.png1024576Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
By Troy Polan, Acting CEO and CTO Sophisticated data capabilities set Excelera apart. Our Complex Patient Data Platform supports dashboards of critical as well as supplementary data for each health…
COVID & Oncology – The Effects on Health System Specialty Pharmacieshttps://shieldshealthsolutions.com/content/uploads/2021/06/EX089-COVID19Infographic_Oncology-1-1-1024x791.png1024791Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
This blog was written by Excelera, a Shields company. Two months ago, our blog discussed the potential impacts and areas of concern for health system specialty pharmacies and COVID. However,…
Orlando Health Provides Patients with Improved Outcomes Through Increased Access to Innovative Oncology Treatments by Joining the Excelera Networkhttps://shieldshealthsolutions.com/content/uploads/2021/06/shields-blog-icon-pr-1.svg204115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Orlando Health is the first health system in Florida to partner with Excelera®, the company behind the Excelera Network, to further optimize its specialty pharmacy services and to provide patients with increased access to limited distribution drugs (LDDs), which include innovative oncology treatments.
Digital Technology: An Effective Communication Tool for Pharmacy Staff During COVID-19https://shieldshealthsolutions.com/content/themes/blade/images/empty/thumbnail.jpg150150Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
By Vinay Sawant, RPh, MPH, MBA; Ayse Hursid, PharmD; Osama Abdelghany, PharmD, MHA, BCOP; and Terri Sue Bukowski, PharmD, CSP The coronavirus disease 2019 (COVID-19) pandemic has resulted in rewriting…
Excelera® and Aptitude Health Partner to Improve Oncology Patient Outcomes Through Combined Clinical Knowledge and Educationhttps://shieldshealthsolutions.com/content/uploads/2021/06/shields-blog-icon-pr-1.svg204115Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Wolfe joins Excelera with significant experience in building strategic pharmaceutical manufacturer relationships for publicly traded and private organizations in the healthcare sector
COVID — Potential Impact on PBMS and Payershttps://shieldshealthsolutions.com/content/uploads/2021/06/COVID-19-Impact-Series-1024x152.jpg1024152Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
Most Americans seem to be moving on from initial COVID-19 panic, and we are seeing states follow suit by systematically putting plans in place to open back up. This post-pandemic…
COVID – Potential Impact on Health System Specialty Pharmacieshttps://shieldshealthsolutions.com/content/uploads/2021/06/COVID-19-Impact-Series-1024x152.jpg1024152Shields Health SolutionsShields Health Solutions//shieldshealthsolutions.com/content/uploads/2021/05/shields-logo-white.svg
COVID-19 has altered life as we know it, including health care, across the United States. Impacts are likely to be seen in pharmacy across various business units, due to changes…